Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 7;17(1):1245–1252. doi: 10.3892/ol.2018.9670

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019, Spandidos Publications

PMC Copyright notice

Figure 5. — The Oxygen-laden MSC-hemo group significantly enhances the effect of chemotherapeutic treatments on gastric cancer cells. (A) 5-fu treatment group for the MKN45 and SGC-7901 cells. It demonstrated that the oxygen-laden MSC-hemo group significantly enhanced the effect of 5-fu treatment on MKN45 and SGC-7901 cells, while the MSC group had no significant difference, compared with the control group. (B) CDDP treatment group for the MKN45 and SGC-7901 cells. It demonstrated that the oxygen-laden MSC-hemo group significantly enhanced the effect of CDDP treatment on MKN45 and SGC-7901 cells, while the MSC group had no significant difference, compared with the control group. *P>0.05, compared with MSC+5-fu or MSC+CDDP; **P<0,05, compared with oxygen-laden MSC-hemo+5-fu or oxygen-laden MSC-hemo+CDDP. MSCs, mesenchymal stem cells; CDDP, cisplatin; 5-fu, 5-fluroouracil.

Figure 5. — The Oxygen-laden MSC-hemo group significantly enhances the effect of chemotherapeutic treatments on gastric cancer cells. (A) 5-fu treatment group for the MKN45 and SGC-7901 cells. It demonstrated that the oxygen-laden MSC-hemo group significantly enhanced the effect of 5-fu treatment on MKN45 and SGC-7901 cells, while the MSC group had no significant difference, compared with the control group. (B) CDDP treatment group for the MKN45 and SGC-7901 cells. It demonstrated that the oxygen-laden MSC-hemo group significantly enhanced the effect of CDDP treatment on MKN45 and SGC-7901 cells, while the MSC group had no significant difference, compared with the control group. *P>0.05, compared with MSC+5-fu or MSC+CDDP; **P<0,05, compared with oxygen-laden MSC-hemo+5-fu or oxygen-laden MSC-hemo+CDDP. MSCs, mesenchymal stem cells; CDDP, cisplatin; 5-fu, 5-fluroouracil.